General
| Symbol | Name | Sector | Industry | Country | Employees |
|---|---|---|---|---|---|
| QNCX.US | Quince Therapeutics, Inc. | Healthcare | Biotechnology | N/A | 38 |
| QTRX.US | Quanterix Corp | Healthcare | Medical Devices | N/A | 450 |
Valuation
| Metric | QNCX.US | QTRX.US |
|---|---|---|
| Market Cap | $32.27M | $144.72M |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | 0.00 | 0.00 |
| P/E Ratio | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price/Book | 2.21 | 0.63 |
| Price/Sales | 0.00 | 0.94 |
| Enterprise Value | $-85.98M | $89.30M |
| EV/Revenue | 0 | 0.5831 |
| EV/EBITDA | 1.4385 | -1.4898 |
Highlights
| Metric | QNCX.US | QTRX.US | Chart |
|---|---|---|---|
| EBITDA | $-60.65M | $-70.50M |
|
| Book Value | -34.73 | 5.03 |
|
| Dividend/Share | N/A | N/A |
|
| Dividend Yield | N/A | N/A |
|
| Earnings/Share | $-214.01 | $-2.61 |
|
| Profit Margin | 0.00% | -80.25% |
|
| Operating Margin | 0.00% | -68.37% |
|
| ROA (TTM) | -31.51% | -16.67% |
|
| ROE (TTM) | -153.84% | -46.49% |
|
| Revenue (TTM) | $0.00 | $153.41M |
|
| Revenue/Share (TTM) | $0.00 | $3.28 |
|
| Earnings Growth (YOY) | 0.00% | 0.00% |
|
| Revenue Growth (YOY) | 0.00% | 34.40% |
|
Price
| Metric | QNCX.US | QTRX.US |
|---|---|---|
| 52 Week High | $910.00 | $8.77 |
| 52 Week Low | $15.10 | $2.15 |
| 50 Day MA | $30.70 | $3.03 |
| 200 Day MA | $88.35 | $4.10 |
Ownership
| Metric | QNCX.US | QTRX.US | Chart |
|---|---|---|---|
| % Insiders | 2.90% | 6.37% |
|
| % Institutions | 34.50% | 71.23% |
|
Custom Spider Plot
Metric Selection
Toggle metrics to customize this spider plot. Values are normalized to 0-100 per selected metric for side-by-side comparison.
Custom Spider Plot (Stocks on Axes)
Metric Selection
Use the same metric selection here. Changes in either selector panel stay synchronized.